Literature DB >> 25777814

Negative symptoms in schizophrenia show association with amygdala volumes and neural activation during affective processing.

Christoffer Rahm1, Benny Liberg2, Greg Reckless3, Olga Ousdal3, Ingrid Melle3, Ole A Andreassen3, Ingrid Agartz3.   

Abstract

OBJECTIVES: Negative symptoms in schizophrenia have been associated with structural and functional alterations of the amygdala. We hypothesised that there would be between-group differences in amygdala volume and neural activation patterns during processing of affective stimuli among patients with schizophrenia and healthy controls. We further hypothesised correlations between neuroimaging metrics and clinical ratings of negative symptoms in patients with schizophrenia.
METHODS: We used structural and functional magnetic resonance imaging to assess volume and neural activation of the amygdala in 28 patients with schizophrenia and 28 healthy controls.
RESULTS: We found no between-group differences in amygdala volume or neural activation. However, we found a significant negative correlation between emotional blunting and neural activation in the left amygdala during processing of positive affect. We also found a significant negative correlation between stereotyped thinking and the volume of right amygdala.
CONCLUSION: Our findings implicate the amygdala in a subgroup of negative symptoms in schizophrenia that are characterised by reduced expression with blunted affect and stereotyped thinking.

Entities:  

Keywords:  amygdala; functional magnetic resonance imaging; magnetic resonance imaging; schizophrenia

Mesh:

Year:  2015        PMID: 25777814     DOI: 10.1017/neu.2015.11

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  9 in total

1.  Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial.

Authors:  Samantha V Abram; Lize De Coster; Brian J Roach; Bryon A Mueller; Theo G M van Erp; Vince D Calhoun; Adrian Preda; Kelvin O Lim; Jessica A Turner; Judith M Ford; Daniel H Mathalon; Joshua D Woolley
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

2.  The percentage and clinical correlates of alexithymia in stable patients with schizophrenia.

Authors:  Yun Yi; Yuanyuan Huang; Rui Jiang; Qiang Chen; Mingzhe Yang; Hehua Li; Yangdong Feng; Shixuan Feng; Sumiao Zhou; Lixin Zhang; Yuping Ning; Zezhi Li; Fengchun Wu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-10-14       Impact factor: 5.760

3.  Neuroanatomical and Symptomatic Sex Differences in Individuals at Clinical High Risk for Psychosis.

Authors:  Elisa Guma; Gabriel A Devenyi; Ashok Malla; Jai Shah; M Mallar Chakravarty; Marita Pruessner
Journal:  Front Psychiatry       Date:  2017-12-22       Impact factor: 4.157

4.  RNA-seq analysis of amygdala tissue reveals characteristic expression profiles in schizophrenia.

Authors:  X Chang; Y Liu; C-G Hahn; R E Gur; P M A Sleiman; H Hakonarson
Journal:  Transl Psychiatry       Date:  2017-08-15       Impact factor: 6.222

5.  Olfactory impairment in first-episode schizophrenia: a case-control study, and sex dimorphism in the relationship between olfactory impairment and psychotic symptoms.

Authors:  Xiacan Chen; Jiajun Xu; Bin Li; Wanjun Guo; Jun Zhang; Junmei Hu
Journal:  BMC Psychiatry       Date:  2018-06-18       Impact factor: 3.630

6.  Deletion of Dtnbp1 in mice impairs threat memory consolidation and is associated with enhanced inhibitory drive in the amygdala.

Authors:  Cathy C Y Huang; Kevin J Muszynski; Vadim Y Bolshakov; Darrick T Balu
Journal:  Transl Psychiatry       Date:  2019-04-09       Impact factor: 6.222

7.  Evidence of an interaction between FXR1 and GSK3β polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics.

Authors:  Antonio Rampino; Silvia Torretta; Barbara Gelao; Federica Veneziani; Matteo Iacoviello; Aleksandra Marakhovskaya; Rita Masellis; Ileana Andriola; Leonardo Sportelli; Giulio Pergola; Alessandra Minelli; Chiara Magri; Massimo Gennarelli; Antonio Vita; Jean Martin Beaulieu; Alessandro Bertolino; Giuseppe Blasi
Journal:  Eur Psychiatry       Date:  2021-04-19       Impact factor: 5.361

8.  Global hypomyelination of the brain white and gray matter in schizophrenia: quantitative imaging using macromolecular proton fraction.

Authors:  Liudmila P Smirnova; Vasily L Yarnykh; Daria A Parshukova; Elena G Kornetova; Arkadiy V Semke; Anna V Usova; Anna O Pishchelko; Marina Y Khodanovich; Svetlana A Ivanova
Journal:  Transl Psychiatry       Date:  2021-06-30       Impact factor: 6.222

9.  Nonclinical psychotic-like experiences and schizotypy dimensions: Associations with hippocampal subfield and amygdala volumes.

Authors:  Ulrika Evermann; Christian Gaser; Tina Meller; Julia-Katharina Pfarr; Sarah Grezellschak; Igor Nenadić
Journal:  Hum Brain Mapp       Date:  2021-07-24       Impact factor: 5.038

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.